Rodger A. Warnke

Q: What Schools Are Affiliated With Rodger A. Warnke

Rodger A. Warnke is affiliated with the following schools: Stanford University, Harvard University

Rodger A. Warnke's AcademicInfluence.com Rankings

Rodger A. Warnke

Philosophy

#4049

World Rank

#6423

Historical Rank

Logic

#1596

World Rank

#2392

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Rodger A. Warnke's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Rodger A. Warnke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rodger A. Warnke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) (9767)
Helicobacter pylori infection and gastric lymphoma. (1994) (1914)
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. (1997) (1012)
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells (1999) (900)
Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. (1989) (874)
Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. (1982) (847)
Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. (1987) (718)
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases (2002) (586)
Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. (1981) (558)
Epstein-Barr viral DNA in tissues of Hodgkin's disease. (1987) (549)
Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. (1997) (533)
Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data (1992) (516)
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system (1989) (505)
Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. (1984) (465)
A clinical trial of anti-idiotype therapy for B cell malignancy. (1985) (461)
Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. (1983) (431)
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. (1993) (409)
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. (1987) (407)
A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. (1986) (383)
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. (1983) (370)
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. (1980) (355)
Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. (1985) (349)
Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. (1993) (335)
Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. (1980) (333)
Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. (1986) (332)
CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 (1990) (321)
Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathologic study of 29 cases (1975) (307)
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. (2002) (305)
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. (2001) (298)
Castleman Disease: An Update on Classification and the Spectrum of Associated Lesions (2009) (296)
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. (1988) (293)
Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. (1984) (291)
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. (2008) (279)
The monoclonality of human B-cell lymphomas (1977) (278)
Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. (1985) (261)
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. (1984) (253)
Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Immunohistologic and Clinical Correlation (2003) (250)
Lymphadenopathy simulating the malignant lymphomas. (1974) (244)
Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes (2002) (241)
Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. (1985) (234)
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. (2013) (228)
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. (1998) (224)
Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. (1985) (223)
Hodgkin's Disease: A clinicopathologic study of 659 cases (1982) (205)
Biclonal B-cell lymphoma. (1984) (205)
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. (1989) (204)
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. (1979) (198)
Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. (1986) (195)
Immunoglobulin gene rearrangements in Hodgkin's disease. (1986) (192)
Expression of CD163 (Hemoglobin Scavenger Receptor) in Normal Tissues, Lymphomas, Carcinomas, and Sarcomas Is Largely Restricted to the Monocyte/Macrophage Lineage (2005) (188)
Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry (2001) (181)
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. (1994) (177)
The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. (2001) (176)
Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. (1978) (175)
Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. (1994) (170)
Pagetoid Reticulosis (Woringer-Kolopp Disease): An Immunophenotypic, Molecular, and Clinicopathologic Study (2000) (170)
CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. (1995) (170)
A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. (1998) (169)
Malignant Fibrous Histiocytoma Tumor Cells Resemble Fibroblasts (1986) (165)
Malignant histiocytosis a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies (1990) (163)
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior (2012) (159)
Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. (1977) (159)
Variation in gene expression patterns in follicular lymphoma and the response to rituximab (2003) (158)
Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. (1991) (157)
Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. (1980) (151)
Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. (1988) (150)
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. (2013) (149)
Histiocytic malignancies: Morphologic, immunologic, and enzymatic heterogeneity (1984) (147)
Non‐hodgkin's lymphoma. A study of the evolution of the disease based upon 92 autopsied cases (1979) (146)
Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. (2000) (145)
Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. (1987) (142)
Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. (1986) (141)
Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody. (1987) (140)
Ovarian Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of Eight Primary Cases (2001) (134)
CD30 expression is common in mediastinal large B-cell lymphoma. (1999) (133)
Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. (1996) (130)
A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies (1983) (129)
Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. (1986) (127)
Immunopathology of follicular lymphomas. A model of B-lymphocyte homing. (1978) (125)
Cutaneous Follicular Lymphoma (1986) (125)
Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. (1986) (120)
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. (2004) (120)
Primary radiotherapy for localized orbital MALT lymphoma. (2002) (120)
Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. (1989) (119)
The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. (2006) (119)
Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. (1992) (118)
LYMPHOMA IN CARDIAC ALLOTRANSPLANT RECIPIENTS: Clinical and Histological Features and Immunological Phenotype (1982) (118)
The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. (1983) (117)
The “Syncytial Variant” of Nodular Sclerosing Hodgkin's Disease (1986) (116)
Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. (1993) (116)
Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. (1987) (115)
The Diagnostic Utility of the Keratin Profiles of Hepatocellular Carcinoma and Cholangiocarcinoma (1988) (113)
Monocytoid B-cell lymphoma: a study of 36 cases. (1991) (113)
A unique human B lymphocyte antigen defined by a monoclonal antibody. (1984) (113)
The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques. (1982) (111)
Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms. (1985) (110)
T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils. (1982) (110)
Spindle Cell Neoplasms of Lymph Nodes of Probable Reticulum Cell Lineage: True Reticulum Cell Sarcoma? (1990) (108)
Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. (1990) (105)
Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. (1999) (105)
Expression of Pbx1b during mammalian organogenesis (2001) (103)
Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. (1984) (101)
Clinical and phenotypic diversity of T cell lymphomas. (1986) (99)
Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders. (1985) (99)
Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. (1989) (98)
Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. (1989) (97)
Expression of a T-cell antigen (Leu-1) by B-cell lymphomas. (1983) (96)
A comparative study of Burkitt's and non‐Burkitt's “undifferentiated” malignant lymphoma: Immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features (1982) (95)
Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. (1989) (94)
Malignant lymphoma with a high content of epithelioid histiocytes. A distinct clinicopathologic entity and a form of so‐called „Lennert's Lymphoma”︁ (1978) (92)
Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms (1985) (91)
T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). (1988) (90)
RANTES chemokine expression in diseased and normal human tissues. (1996) (90)
Expression of bcl‐2 protein and Ki‐67 nuclear proliferation antigen in benign and malignant cutaneous T‐cell infiltrates (1995) (89)
A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry. (1978) (89)
The lymphoid system. Its normal architecture and the potential for understanding the system through the study of lymphoproliferative diseases. (1978) (88)
The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. (1984) (88)
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) (1994) (88)
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. (2008) (87)
Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. (1987) (86)
Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience. (1991) (86)
bcl‐2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas (1994) (85)
Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. (1988) (84)
The coexistence of nodular and diffuse patterns in nodular non‐Hodgkin's lymphomas. Significance and clinicopathologic correlation (1977) (83)
B‐lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology (1999) (82)
Endodermal sinus tumor. The stanford experience and the first reported case arising in the vulva (1978) (80)
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. (2006) (79)
Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas. (1987) (78)
Carcinoma of the nasopharynx--the significance of histology. (1978) (77)
Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas. (1984) (77)
Peripheral T-cell lymphoma complicated by a proliferation of large B cells. (2000) (74)
Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas: A Phenomenon With Distinctive Clinicopathologic Features (2007) (72)
Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. (1993) (71)
Anaplastic Large‐Cell Lymphoma (2011) (70)
Primary mediastinal non-Hodgkin's lymphomas: a morphologic and immunologic study of 19 cases. (1985) (70)
Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia. (1982) (69)
Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. (1993) (69)
PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis (2010) (68)
Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. (1990) (67)
MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. (1997) (67)
Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to primary cutaneous epithelial neoplasms (1998) (66)
Morphologic types of diffuse large‐cell lymphoma (1982) (65)
An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern. (1988) (64)
Splenic B‐Cell Marginal Zone Lymphoma (2011) (63)
Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings. (1989) (63)
Expression of LFA‐1 in non‐hodgkin's lymphoma (1989) (62)
TdT+ T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma (2012) (62)
Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. (1994) (62)
Mycosis fungoides skin lesions contain CD8+ tumor‐infiltrating lymphocytes expressing an activated, MHC‐restricted cytotoxic T‐lymphocyte phenotype (1994) (61)
Lack of human herpesvirus 8 and Epstein-Barr virus in Kikuchi's histiocytic necrotizing lymphadenitis. (2003) (60)
Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammation. (1986) (60)
Immunobiology of a Spontaneous Murine B Cell Leukemia (BCL1) (1979) (60)
Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. (1989) (60)
Immunohistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. Evidence for their interrelationship with lymphomatoid papulosis. (1987) (60)
Inflammatory Pseudotumor of Lymph Nodes: Additional Observations and Evidence for an Inflammatory Etiology (1991) (59)
Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. (1989) (58)
Large-cell hematolymphoid neoplasms of uncertain lineage. (1988) (58)
A unique antigen on mature B cells defined by a monoclonal antibody. (1986) (57)
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. (1988) (57)
Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. (1995) (56)
Gastrointestinal lymphomas: Immunohistochemical studies on the cell of origin (1985) (56)
Immunoglobulin gene rearrangements in hairy cell leukemia. (1984) (56)
Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. (1996) (55)
Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. (1992) (55)
Vascular Transformation of Sinuses in Lymph Nodes: A Study of Its Morphological Spectrum and Distinction From Kaposi's Sarcoma (1991) (54)
Primary large-cell lymphoma of the thymus: a diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. (1990) (54)
The nephrotic syndrome in massive obesity: a study by light, immunofluorescence, and electron microscopy. (1978) (54)
Pregnancy‐associated lymphomas: A clinicopathologic study (1996) (53)
Intermediate lymphocytic lymphoma: an immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. (1988) (53)
Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations. (1988) (52)
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. (2009) (51)
Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. (1995) (51)
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. (1989) (51)
Most null large cell lymphomas are B lineage neoplasms. (1985) (51)
Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas. (1989) (50)
Clinical significance of morphologic subdivision in diffuse large cell lymphoma (1991) (50)
Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma (2013) (50)
Small noncleaved cell lymphoma: an immunophenotypic study of 18 cases and comparison with large cell lymphoma. (1986) (50)
Monoclonal anti-keratin (AE1) reactivity in routinely processed tissue from 166 human neoplasms. (1985) (50)
Idiotype variant cell populations in patients with B cell lymphoma (1986) (50)
Follicular lymphomas with plasmacytic differentiation include two subtypes (2010) (49)
Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. Case report. (2002) (49)
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. (2012) (48)
Hodgkin's disease at autopsy: 1972–1977 (1981) (47)
Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies. (1985) (47)
Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. (1994) (47)
Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. (2000) (46)
Diagnosis of B cell lymphoma by analysis of immunoglobulin gene rearrangements in biopsy specimens obtained by fine needle aspiration. (1986) (46)
Non-Hodgkin's lymphoma containing both B and T cell clones. (1987) (46)
Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components (2010) (45)
Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. (1994) (45)
Primary low-grade endometrial B-cell lymphoma. (1997) (45)
Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. (1989) (44)
Hydroa‐like lymphoma with CD56 expression (2008) (44)
Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas. (1987) (44)
Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response. (1985) (44)
Expression of Leu-8 antigen, a majority T-cell marker, is uncommon in mycosis fungoides. (1985) (44)
Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity. (1992) (43)
A case of Woringer-Kolopp disease with Ki-1 (CD30) + cytotoxic/suppressor cells. (1992) (42)
Alteration of immunoglobulin-bearing lymphoma cells by fixation. (1979) (42)
The Cells of Giant Cell Tumor of Tendon Sheath Resemble Osteoclasts (1988) (41)
Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases. (2000) (41)
Morphologic and immunophenotypic variants of nodal T-cell lymphomas and T-cell lymphoma mimics. (2007) (41)
Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases (2000) (41)
True histiocytic lymphoma: a study of 12 cases based on current definition. (1995) (41)
Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression. (1988) (41)
Lymphocytic infiltrates of the conjunctiva and orbit: immunohistochemical staining of 16 cases. (1984) (40)
Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry. (1987) (40)
In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS. (1986) (40)
Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. (2010) (40)
Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. (1985) (39)
Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results (2012) (39)
Non-Hodgkin's lymphomas of the lung: A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis (1985) (39)
Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma (1988) (39)
Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. (1997) (38)
V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. (1995) (38)
"Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features. (1987) (38)
Light‐chain‐restricted germinal centres in reactive lymphadenitis: report of eight cases (2008) (38)
Detection ofT and B Cell Antigens with Hybridoma Monoclonal Antibodies: A Biotin-Avidin-Horseradish Peroxidase I (1980) (37)
IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma. (2012) (37)
The immunohistology of follicle lysis in lymph node biopsies from homosexual men. (1985) (37)
The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma (1994) (36)
Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. (2000) (36)
PCR-Heteroduplex Analysis of T-Cell Receptor &ggr; Gene Rearrangement in Paraffin-Embedded Skin Biopsies (2000) (36)
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. (2002) (36)
Clonal VDJ recombination of the immunoglobulin heavy chain gene by PCR in classical Hodgkin's disease. (1995) (35)
The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas. (2008) (35)
Endogenous Avidin-binding Activity in Paraffin-embedded Tissue Revealed after Microwave Treatment (1997) (35)
Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma. (2015) (35)
Transferrin receptor expression by non‐hodgkin's lymphomas. Correlation with morphologic grade and survival (1988) (34)
Di erent types of di use large b-cell lymphoma identi ed by gene expression pro ling (2000) (34)
True histiocytic lymphoma following therapy for lymphoblastic neoplasms. (1996) (33)
Leu-6-expressing cells in lymph nodes: dendritic cells phenotypically similar to interdigitating cells. (1986) (33)
Malignant Histiocytic Neoplasms of the Small Intestine (1992) (32)
Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). (1993) (31)
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. (2018) (31)
Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems. (1984) (31)
Expression of FKBP12 in Benign and Malignant Vascular Endothelium: An Immunohistochemical Study on Conventional Sections and Tissue Microarrays (2003) (31)
Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients. (2004) (31)
An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas. (1989) (30)
Lymphoma in Cardiac Transplant Recipients Associated with Cyclosporin A, Prednisone and Anti-Thymocyte Globulin (ATG) (1984) (29)
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. (2013) (29)
Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study. (1986) (29)
Extranodal head and neck lymphomas in Guatemala: high frequency of Epstein-Barr virus-associated sinonasal lymphomas. (1997) (28)
Diffuse malignant lymphoma with cerebriform nuclei: A B-cell lymphoma studied with monoclonal antibodies. (1985) (28)
Immune signatures in follicular lymphoma. (2005) (28)
Herpes lymphadenitis in association with chronic lymphocytic leukemia (1999) (27)
CD45 epitope mapping of human CD1a+ dendritic cells and peripheral blood dendritic cells. (1991) (27)
Infrequent detection of Toxoplasma gondii genome in toxoplasmic lymphadenitis: a polymerase chain reaction study. (1992) (27)
Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases (1987) (26)
Follicular large cell lymphoma. An immunophenotype study. (1986) (26)
BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5′ regulatory region of the BCL-6 gene (2002) (25)
Lymphomas presenting as histologically unclassified neoplasms: characteristics and response to treatment. (1989) (25)
Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. (2005) (25)
A quantitative comparison of t‐cell subsets in hodgkin's disease and reactive hyperplasia frozen section immunohistochemistry (1984) (25)
Histochemistry of Hodgkin's disease. (1982) (25)
A panel approach to the evaluation of the sensitivity and specificity of antibodies for the diagnosis of routinely processed histologically undifferentiated human neoplasms. (1987) (25)
Ki-1 (CD30) expression in differentiation of lymphomatoid papulosis from arthropod bite reactions. (1992) (25)
Clonal antigen receptor gene rearrangements and epstein‐barr viral DNA in tissues of Hodgkin's disease (1988) (25)
ALK‐negative systemic intravascular anaplastic large cell lymphoma presenting in the skin (2011) (25)
BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma. (1997) (24)
Malignant lymphoma presenting as pseudoepitheliomatous hyperplasia. A report of two cases. (1988) (24)
Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4. (1998) (24)
Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation. (1999) (24)
A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. (1983) (24)
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells (2006) (23)
Intravascular ALK-positive anaplastic large-cell lymphoma mimicking inflammatory breast carcinoma. (2009) (22)
Necrosis in lymph nodes. (1987) (22)
Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma. (1997) (22)
Follicular Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell Lymphoma (2005) (22)
Identification and significance of cell markers in leukemia and lymphoma. (1983) (22)
The histology of the initial relapse of Hodgkin's disease (1980) (22)
Mutational Analysis of IgVH and BCL-6 Genes Suggests Thymic B-cells Origin of Mediastinal (Thymic) B-cell Lymphoma (2004) (21)
An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified. (2016) (21)
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow. (2011) (21)
CyclinD1/CyclinD3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma. (2004) (21)
Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphoma (1987) (20)
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas (2014) (20)
Warthin-Finkeldey polykaryocytes demonstrate a T-cell immunophenotype. (1992) (20)
Indolent T-lymphoblastic Proliferation With Disseminated Multinodal Involvement and Partial CD33 Expression (2014) (19)
Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non‐Hodgkin's lymphoma (1988) (19)
The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL). (1986) (19)
Systemic panniculitis‐like T‐cell lymphoma with involvement of mesenteric fat and subcutis (2015) (19)
Heterogeneity of CD3 antigen expression in T‐cell lymphoma (1993) (18)
Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. (1999) (18)
Expression of the Leu-8 antigen by B-cell lymphomas. (1987) (18)
In situ localization of HuHF serine protease mRNA and cytotoxic cell-associated antigens in human dermatoses. A novel method for the detection of cytotoxic cells in human tissues. (1988) (16)
The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. (1994) (16)
Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003. (2007) (16)
REVERSIBLE LYMPHOMAS. AUTHORS' REPLY (1993) (16)
Primary cutaneous gamma delta T-cell lymphoma with brain involvement and hemophagocytic syndrome. (2013) (15)
Sinusoidal hematolymphoid malignancy (“malignant histiocytosis”) presenting as atypical sinusoidal proliferation: A study of nine cases (1986) (15)
Metastatic carcinoma in lymph nodes simulating "syncytial variant" of nodular sclerosing Hodgkin's disease. (1991) (15)
Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome. (1993) (15)
Pregnancy-associated lymphomas. A clinicopathologic study. (1996) (15)
Differentiation of chronic lymphocytic leukemia from Hodgkin's disease using immunologic marker studies (1981) (14)
Follicular lymphoma with blastic conversion: a report of two cases with confirmation by immunoperoxidase studies on bone marrow sections. (1985) (14)
Radiographic manifestations of malignant histiocytosis. (1976) (14)
Expression of T cell antigens by cells in mouse and human primary and secondary follicles. (1982) (14)
Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA. (1991) (14)
Immunophenotypic and Genotypic Characterization of Progression in Follicular Lymphomas (2004) (14)
Diffuse large B-cell lymphoma with aberrant expression of the T-cell antigens CD2 and CD7. (2011) (13)
Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. (2008) (13)
The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques (1982) (13)
Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. (2009) (13)
The immunohistology of non-T cells in the acquired immunodeficiency syndrome. (1985) (13)
Expression of Tac antigen by non-Hodgkin's lymphomas. (1987) (12)
Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis. (1985) (12)
Bone Marrow Diagnosis (2006) (12)
Utility of molecular genetic analysis for the diagnosis of neoplasia in morphologically and immunophenotypically equivocal hematolymphoid lesions (1991) (12)
Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma (2019) (12)
The distinction of Hodgkin's disease from B cell lymphoma. (1992) (11)
Coexistence of Nodular Lymphocyte Predominance Hodgkin's Disease and Hodgkin's Disease of the Usual Type (1993) (10)
Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications (2016) (10)
Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody specific for immunoglobulin M. (1992) (10)
Establishing a KSHV1 Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice (1998) (10)
Variable Expression of B-cell Transcription Factors in Reactive Immunoblastic Proliferations: A Potential Mimic of Classical Hodgkin Lymphoma (2014) (9)
A Comprehensive Analysis of Rhoa Mutation Positive and Negative Angioimmunoblastic T-Cell Lymphomas By Targeted Deep Sequencing, Expression Profiling, and Single Cell Digital Image Analysis (2019) (9)
Evidence that mycosis fungoides mf and transformed mf arise from the same t cell clone (1991) (8)
EXPRESSION OF CLASS II MAJOR HISTOCOMPATIBILITY ANTIGENS BY KERATINOCYTES IN CUTANEOUS T CELL LYMPHOMA (1994) (8)
Establishing a KSHV 1 Cell Line ( BCP-1 ) From Peripheral Blood and Characterizing Its Growth in Nod / SCID Mice (1998) (8)
Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant. (2015) (7)
PREGNANCY-ASSOCIATED LYMPHOMAS : A CLINICOPATHOLOGICAL STUDY (1997) (7)
Composite dendritic cell neoplasm (NOS) and small lymphocytic lymphoma. (2000) (7)
T‐Cell Large Granular Lymphocytic Leukaemia and Aggressive NK‐Cell Leukaemia (2011) (7)
Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas. (1991) (7)
B‐cell prolymphocytic leukaemia (2011) (6)
Angiocentric lymphomas (lymphomatous vasculitis). (2001) (6)
The Number of CD25+ Tumor-Infiltrating Cells May Predict Clinical Response to Rituximab in Follicular Lymphoma Patients. (2004) (6)
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab. (2001) (5)
Large B-cell lymphoma of thyroid. Two cases with a marginal zone distribution of the neoplastic cells. (2000) (5)
TNFRSF6 (Fas Antigen) Mutations in Patients with Sinus Histiocytosis with Massive Lymphadenopathy (Rosai-Dorfman Disease). (2004) (5)
Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma? (2012) (5)
Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma. (1992) (5)
Distribution of monoclonal antiferritin antibody in Kaposi's sarcoma, Hodgkin's disease, and hepatocellular carcinoma. (2003) (4)
An Unusual Progression of Follicular Lymphoma Mimicking T-Cell and Histiocyte-Rich Large B-Cell Lymphoma (2014) (4)
CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. (2020) (4)
Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma (2009) (4)
LIM domain only 2 (LMO2) expression distinguishes T‐lymphoblastic leukemia/lymphoma from indolent T‐lymphoblastic proliferations (2020) (4)
Immunologic phenotype in large-cell lymphoma. (1980) (4)
Immunocytochemical detection of human T- and B-cell antigens. (1990) (4)
Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue (2010) (4)
B-cell malignant lymphomas: an immunologic perspective. (1987) (4)
Extracavity primary effusion lymphoma presenting in a lymph node without lymphomatous effusions (2015) (3)
Tumor progression in malignant lymphomas. (1991) (3)
Basic References (3)
Indolent T-lymphoblastic proliferation: a name with specific meaning. (2015) (3)
The Diagnosis of Lymphoproliferative Diseases: Gatter/The Diagnosis of Lymphoproliferative Diseases (2011) (3)
Processing of the Lymph Node Biopsy Specimen (2011) (3)
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis (2020) (3)
The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma. (1997) (3)
82 Primary radiotherapy is curative for CS IE orbital MALT lymphoma (1997) (2)
Leukocyte common antigen expression in lymphomas. (1988) (2)
Intralymphatic Rosai-Dorfman Disease Associated With Vulvar Lymphedema: A Case Report of an Extremely Rare Phenomenon. (2020) (2)
The immunobiology of B cell lymphoma: clonal heterogeneity as revealed by anti-idiotype antibodies and immunoglobulin gene probes. (1986) (2)
Marked Improvement in Staging Accuracy in Mycosis Fungoides/Sézary Syndrome Using Integrated Positron Emission Tomography and Computed Tomography (PET/CT). (2004) (2)
Uterine Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy). (2014) (2)
Extranodal NK/T‐Cell Lymphomas: Nasal Type (2011) (2)
T‐Cell Lymphoblastic Lymphoma/Leukaemia (2011) (2)
The immunobiology of B-cell lymphoma. Studies with anti-idiotype antibodies (1985) (2)
Cutaneous T-Cell Lymphomas (2004) (2)
Methods for decreasing interstitial immunoglobulin in tissue slices and cryostat sections (1983) (2)
The Diagnosis of Lymphoproliferative Diseases (2011) (2)
Closing the gap: A comparison of observed versus expected survival in follicular lymphoma (FL) at Stanford University from 1960-2003 (2008) (2)
Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL (2011) (2)
Prognostic significance of CD15 expression in classical Hodgkin lymphoma (cHL): The Stanford University experience. (2010) (1)
Vascular Transformation of Lymph Node Sinuses (1992) (1)
Comprar The Diagnosis Of Lymphoproliferative Diseases | Kevin Gatter | 9781405170147 | Wiley (2011) (1)
Mantle Cell Lymphoma (2011) (1)
Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing (2019) (1)
Fatal post-transfusion acquired immunodeficiency in a heterosexual man: quantitative lymph node immunopathology. (1988) (1)
definitive hematopoiesis in the fetal liver The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of (2013) (1)
A 20-Year Consecutive Case Series From a Tertiary Cancer Center (2020) (1)
Discordant Expression ofAntigens Between Intraepidermal andIntradermal TCells inMycosis Fungoides (1990) (1)
29. Histiocytic Sarcoma (2011) (0)
Follicular Dendritic Cell Proliferations and Related Entities (2011) (0)
Ef fi cacy of abbreviated Stanford V chemotherapy and involved-fi eld radiotherapy in early-stage Hodgkin lymphoma : mature results of the G 4 trial † (2013) (0)
clone sarcomas: evidence for transdifferentiation of the follicular lymphoma Clonally related follicular lymphomas and histiocytic/dendritic cell (2013) (0)
Reactive and Infective Conditions (2011) (0)
Immunodeficiency‐Associated Lymphoproliferative Disorders (2011) (0)
Lymphoplasmacytic Lymphoma (Including Waldenström Macroglobulinemia) (2006) (0)
produces interferon-gamma (see comments) SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features (2013) (0)
Variability of Immunoglobulin Expression in Follicular Lymphoma (2007) (0)
Langerhans Cell Histiocytosis (2011) (0)
The Normal Bone Marrow (2006) (0)
Large Granular Lymphocyte Leukemia (2006) (0)
‘ ‘ focus on . . . ’ ’ session : transformation 086 SNP ARRAY GENOTYPING IN 182 DIAGNOSTIC FOLLICULAR LYMPHOMA CASES IDENTIFIES SITES OF AUPD ASSOCIATED WITH OVERALL SURVIVAL AND RISK OF TRANSFORMATION (2008) (0)
Adult T‐Cell Lymphoma/Leukaemia (2011) (0)
Marginal Zone B Cell Lymphoma (Including Malt Type) (2006) (0)
Author reply (0)
Peripheral T Cell Lymphomas, Unspecified (2006) (0)
Immature T-Cell Populations in Lymph Nodes of Castleman Disease and Angioimmunoblastic T-Cell Lymphoma Suggest Alternate Sites of T-Cell Development, (2011) (0)
15. Burkitt Lymphoma (2011) (0)
Co-Expression of L 60 ( Leu-22 ) and L 26 Antigens Correlates with Malignant Histologic Findings (2016) (0)
Subcutaneous Panniculitis‐Like T‐Cell Lymphoma and Primary Cutaneous γ/δ T‐Cell Lymphoma (2011) (0)
An Introduction to Lymphoma Diagnosis (2011) (0)
antibodies : correlation with clinical responses Studies on B lymphoid tumors treated with monoclonal anti-idiotype (2005) (0)
Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease (2017) (0)
9. Lymphoplasmacytic Lymphoma (2011) (0)
Angioimmunoblastic T‐Cell Lymphoma (2011) (0)
Hairy Cell Leukemia (2006) (0)
A comprehensive analysis of RHOA mutation positive (2020) (0)
Short Title: Survival in Follicular Lymphoma (2017) (0)
Human Germinal Center–associated Lymphoma (HGAL) Is a Reliable Marker of Normal and Neoplastic Follicular Helper T Cells Including Angioimmunoblastic T-Cell Lymphoma (2021) (0)
somatic mutation of the translocated Bcl-2 gene Morphologic transformation of follicular lymphoma is associated with (2011) (0)
Morphologic, immunologic and genetic features of B cell CLL/SLL and immunocytoma (1999) (0)
The Myelodysplastic Syndromes (2006) (0)
Erratum: PD-1 expression in T-cell lymphomas and reactive lymphoid entities: Potential overlap in staining patterns between lymphoma and viral lymphadenitis (American Journal of Surgical Pathology (2010) 34 (178-189)) (2010) (0)
germinal center B-cell gene expression profile The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a (2013) (0)
Peripheral T‐Cell Lymphoma (2011) (0)
Mycosis Fungoides/Sézary Syndrome (2011) (0)
Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (2006) (0)
B‐Cell Lymphoblastic Leukaemia/Lymphoma (2011) (0)
Indolent T‐lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases (2022) (0)
Resistance in Patients ' Tumors : Consensus Recommendations Methods to Detect P-Glycoprotein-associated Multidrug Updated (2006) (0)
Enteropathy‐Associated T‐Cell Lymphoma (2011) (0)
Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors: (2013) (0)
Myeloid Leukaemias (Myeloid Sarcoma) (2011) (0)
Hairy Cell Leukaemia (2011) (0)
A Meta-Analysis of Genetic Abnormalities and Next Generation Sequencing of Primary Cases of Castleman Disease (2019) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
Chronic Lymphocytic Leukemia (2006) (0)
Morphologic, immunologic and genetic features of diffuse large B cell lymphomas (1999) (0)
Chronic Myelogenous Leukemia Presenting as Extramedullary Lymphoid Blast Crisis (2002) (0)
Lymphocytic Neoplasms Immunologic Findings Correlated WithClinical Presentation andMorphologic Features (1987) (0)
Anaemias and Aplasias (2006) (0)
Hepatosplenic T‐Cell Lymphoma (2011) (0)
Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, PDGFRB Mutation and p53 Expression: Clonal Origins of a Rare Disease (2022) (0)
Human Immunodeficiency Virus Infection (2006) (0)
BCL-2 oncogene in the origin of Hodgkin's disease from follicular lymphoma (1995) (0)
Morphologic, immunologic and genetic features of angioimmunoblastic T cell lymphoma (AILD) (1999) (0)
The Diagnosis of Lymphoproliferative Diseases: Second Edition (2011) (0)
rearrangements of chromosome 7 band q34 Clinical and biologic characterization of T-cell neoplasias with (2011) (0)
On the Shoulders of a Giant: Contributions of Thomas Grogan, MD to Hematopathology (2021) (0)
high-grade but not low-grade human lymphomas An epitope of the transferrin receptor is exposed on the cell surface of (2011) (0)
Marginal Zone B‐Cell Lymphoma (Extranodal Malt and Nodal Types) and Extranodal Malt Lymphoma (2011) (0)
Real-time pcr assay for quantitation of BCL-6 mRNA (2000) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rodger A. Warnke?

Rodger A. Warnke is affiliated with the following schools: